| http://www.w3.org/ns/prov#value | - If everything goes Amarin's ways in the next 3 months, Vascepa has such potential, especially if EPA does indeed moderate inflammation which may be the root problem behind most of our chronic degenerative disease including heart disease and diabetes that JesselLivermore wrote in his comment on Ross Klosterman's article on Amarin And Teva: The Court Ruling And Amarin's Outlook on 09/13/2013 at Se
|
